[New agents in chemotherapy and new methods of their administration in the treatment of metastatic cancer of the breast].
Chemotherapy of metastatic breast cancer induces temporary tumor responses, without any incidence on vital prognosis. New drugs are sometimes less toxic than previous but are not more efficient. Such findings are observed with other schedules of chemotherapy. It is necessary to adapt treatment to expected goal: optimal efficacy or minimal toxicity.